Delivery Order SPE2DB20D7066-SPE2DB25FC3NK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for Provocholine inhalation solution in 18mL packs, with a ceiling value of $7,016.62 and a firm fixed price structure. The order is scheduled for completion by September 24, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18ML packs under a firm fixed-price contract with a ceiling value of $1,804.77. This non-competitive delivery order is set to conclude on August 28, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Provocholine is a bronchial challenge agent used in pulmonary function...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 7, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $3,409.63 and an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,642.65 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ml pack configuration. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,809.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18-milliliter pack, with a completion date of December 12, 2025. This non-set-aside competitive award represents a single delivery order positioned as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml pack quantities, with a ceiling value of $2,210. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with a completion deadline of September 9, 2025. This award utilizes no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a ceiling value of $2,601.79. This competitive award, made without a set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The order is expected to be completed by August 27, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine Inhalation Solution in an 18ML pack format. This $25.1K firm fixed-price contract, issued on September 15, 2025, with a completion date of September 16, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3NKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Provocholine inhalation solution in an 18 mL pack, with a ceiling value of $4,587.72 and a firm fixed price structure. The contract represents a non-competitive, competitively awarded delivery order with an ultimate completion date of June 2, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order for Provocholine, a bronchial challenge agent used in pulmonary function testing, aligns with the company's established role as a key supplier of specialized medications and diagnostic products to support defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 5/30/25 |